CN1168506C - Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof - Google Patents
Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof Download PDFInfo
- Publication number
- CN1168506C CN1168506C CNB021163499A CN02116349A CN1168506C CN 1168506 C CN1168506 C CN 1168506C CN B021163499 A CNB021163499 A CN B021163499A CN 02116349 A CN02116349 A CN 02116349A CN 1168506 C CN1168506 C CN 1168506C
- Authority
- CN
- China
- Prior art keywords
- polyhydroxybutyrate
- hours
- solution
- preparation
- polyethylene glycol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000463 material Substances 0.000 title claims abstract description 32
- 229920000331 Polyhydroxybutyrate Polymers 0.000 title claims abstract description 30
- 239000005015 poly(hydroxybutyrate) Substances 0.000 title claims abstract description 30
- 238000002360 preparation method Methods 0.000 title claims abstract description 7
- 229920001223 polyethylene glycol Polymers 0.000 title claims description 17
- 239000002202 Polyethylene glycol Substances 0.000 title claims description 16
- 239000011148 porous material Substances 0.000 claims abstract description 18
- 229920000151 polyglycol Polymers 0.000 claims abstract 5
- 239000010695 polyglycol Substances 0.000 claims abstract 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical group ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 22
- 238000001035 drying Methods 0.000 claims description 19
- 239000000839 emulsion Substances 0.000 claims description 7
- 239000008367 deionised water Substances 0.000 claims description 5
- 229910021641 deionized water Inorganic materials 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 4
- 239000003960 organic solvent Substances 0.000 claims description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 229940079593 drug Drugs 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 229920000136 polysorbate Polymers 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- OBNCKNCVKJNDBV-UHFFFAOYSA-N ethyl butyrate Chemical compound CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 claims 2
- 238000010438 heat treatment Methods 0.000 claims 2
- 206010013786 Dry skin Diseases 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 8
- 238000007710 freezing Methods 0.000 abstract description 6
- 230000008014 freezing Effects 0.000 abstract description 6
- 238000004108 freeze drying Methods 0.000 abstract description 4
- 210000000845 cartilage Anatomy 0.000 abstract description 3
- 230000012010 growth Effects 0.000 abstract description 3
- 239000002028 Biomass Substances 0.000 abstract description 2
- 239000003519 biomedical and dental material Substances 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 abstract 2
- 210000003701 histiocyte Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 8
- 238000012546 transfer Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 5
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical group CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 description 2
- 229920000954 Polyglycolide Polymers 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000007857 degradation product Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 239000004633 polyglycolic acid Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000005859 cell recognition Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000003709 heart valve Anatomy 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Landscapes
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域Technical field
本发明属于生物医学材料科学工程领域用的多孔支架。The invention belongs to a porous support used in the field of biomedical material science and engineering.
背景技术 Background technique
组织工程学是运用工程科学与生命科学的基本原理,研究与开发生物替代物来恢复、维持和改进组织功能的一门新兴学科。其基本思路是:在体外分离、培养细胞,将一定量的细胞种植到具有一定形状的三维生物材料骨架内,并加以持续培养,最终形成具有一定结构的组织和器官并回植体内达到修复或重建的目的。聚羟基丁酸酯(PHB)是微生物在不平衡生长条件下储存于细胞内的一种高分子聚合物,广泛存在于自然界许多原核生物中。PHB具有很多优良的生物和理化性能,如:生物可降解性,生物相容性,压电性,光学活性,无毒性,无刺激性,无免疫原性等特殊性质。这些特性使其在生物医学方面应用广泛,如用作药物释放载体组织工程支架材料。目前组织工程支架材料多是合成类聚酯,如聚乳酸(PLA)、聚乙醇酸(PGA)等,由于它们是合成材料,缺乏细胞识别信号,且其降解产物呈酸性,产物的PH脉冲作用在一定程度上造成无菌炎症;而PHB则不存在此类问题,PHB是微生物合成的高分子聚合物,具有天然生物材料所含的信息有利于细胞附着或保持分化功能,且其最终降解产物为3-羟基丁酸,它在人体血液中是一种普通的代谢物,不会给人体带来任何毒性作用。Tissue engineering is an emerging discipline that uses the basic principles of engineering science and life science to research and develop biological substitutes to restore, maintain and improve tissue functions. The basic idea is: separate and cultivate cells in vitro, plant a certain amount of cells into a three-dimensional biomaterial skeleton with a certain shape, and continue to cultivate them, and finally form tissues and organs with a certain structure and implant them back into the body to achieve repair or repair. purpose of reconstruction. Polyhydroxybutyrate (PHB) is a high molecular polymer stored in the cells of microorganisms under unbalanced growth conditions, and is widely found in many prokaryotes in nature. PHB has many excellent biological and physical and chemical properties, such as: biodegradability, biocompatibility, piezoelectricity, optical activity, non-toxic, non-irritating, non-immunogenic and other special properties. These characteristics make it widely used in biomedicine, such as being used as drug release carrier tissue engineering scaffold material. At present, tissue engineering scaffold materials are mostly synthetic polyesters, such as polylactic acid (PLA), polyglycolic acid (PGA), etc., because they are synthetic materials, lack cell recognition signals, and their degradation products are acidic, and the pH pulse effect of the products To a certain extent, it causes aseptic inflammation; while PHB does not have such problems. PHB is a high molecular polymer synthesized by microorganisms. It has information contained in natural biological materials that is conducive to cell attachment or maintenance of differentiation functions, and its final degradation products It is 3-hydroxybutyric acid, which is a common metabolite in human blood and will not bring any toxic effects to the human body.
PHB在组织工程支架材料的应用方面有许多,目前研究较多的是在软骨、骨、皮肤、心脏瓣膜、血管、神经等组织工程方面。但是纯PHB材料的亲水性较差,不利于细胞在材料表面的粘附和生长。聚乙二醇是被美国FDA批准可内服的无毒的聚合物,具有优良的血液相容性,极好的亲水性,无免疫原性等优点而在药学和生物医用材料领域得到广泛应用。如果用PEG来修饰PHB材料,可以很好地改善材料的亲/疏水性,并能提高材料表面的血液相容性。There are many applications of PHB in tissue engineering scaffold materials. At present, most of the researches are on cartilage, bone, skin, heart valve, blood vessel, nerve and other tissue engineering. However, pure PHB material has poor hydrophilicity, which is not conducive to the adhesion and growth of cells on the surface of the material. Polyethylene glycol is a non-toxic polymer approved by the US FDA for oral administration. It has excellent blood compatibility, excellent hydrophilicity, and no immunogenicity. It is widely used in the fields of pharmacy and biomedical materials. . If PEG is used to modify the PHB material, the hydrophilicity/hydrophobicity of the material can be well improved, and the blood compatibility of the surface of the material can be improved.
另外,做为组织工程支架材料,其孔径大小及分布对细胞的粘附与生长都有影响,如果能控制材料孔径大小及分布,则可使材料适应不同细胞的培养要求。采用单一的冷冻干燥法制得的支架材料,孔径较大且分布不均,而本发明采用冷冻干燥法结合模板法则可人为控制和调节孔洞的大小及分布,使所得支架材料能适用于多种细胞的培养。In addition, as a tissue engineering scaffold material, its pore size and distribution have an impact on cell adhesion and growth. If the pore size and distribution of the material can be controlled, the material can be adapted to the culture requirements of different cells. The scaffold material obtained by a single freeze-drying method has a large pore size and uneven distribution, while the present invention uses the freeze-drying method combined with the template method to artificially control and adjust the size and distribution of the pores, so that the obtained scaffold material can be applied to a variety of cells cultivation.
发明内容Contents of Invention
本发明的目的是改进PHB的亲水性,增强其孔径大小及分布的可控性,同时保留其良The purpose of the present invention is to improve the hydrophilicity of PHB, enhance the controllability of its pore size and distribution, while retaining its good
好的细胞相容性,以适应不同类型细胞的需要。Good cytocompatibility to meet the needs of different types of cells.
本发明的目的是这样实现的:采用聚乙二醇和聚羟基丁酸酯为基材,其重量百分比为1~7∶10。制备方法如下:The object of the present invention is achieved like this: polyethylene glycol and polyhydroxybutyrate are used as base materials, and the weight percentage is 1-7:10. The preparation method is as follows:
1.将一定量的分子量为4000~20000的聚乙二醇和分子量为200000~600000的聚羟基丁酸酯以1~7∶10的重量百分比溶于有机溶剂中。一溶剂可选择氯仿、二氧六环、四氢趺喃等有机溶剂—配制成3~15%重量百分比的溶液;1. A certain amount of polyethylene glycol with a molecular weight of 4,000 to 20,000 and polyhydroxybutyrate with a molecular weight of 200,000 to 600,000 are dissolved in an organic solvent at a weight percentage of 1 to 7:10. 1. The solvent can be an organic solvent such as chloroform, dioxane, tetrahydrofuran, etc.—prepared to a solution of 3% to 15% by weight;
2.模板的制备:取一定量的模板物质—本实验采用的模板有SPAN类、TWEEN类、AOT等—加热溶于去离子水中,形成稳定的乳液;2. Preparation of template: Take a certain amount of template material—the templates used in this experiment include SPAN, TWEEN, AOT, etc.—heat and dissolve in deionized water to form a stable emulsion;
3.将模板乳液与聚羟基丁酸酯/聚乙二醇溶液混合,高速(500~1000转/分钟)搅拌2~4小时,待溶液混合均匀稳定后,转移至化学性能稳定,且耐低温的平底容器中形成1~10mm高度的液面;3. Mix the template emulsion with polyhydroxybutyrate/polyethylene glycol solution, and stir at high speed (500-1000 rpm) for 2-4 hours. After the solution is uniformly mixed and stable, transfer to a chemically stable and low-temperature-resistant A liquid level of 1-10mm height is formed in a flat-bottomed container;
4.将溶液置入-10℃~-80℃的冰箱中预冻8~24小时;将冷冻干燥机干燥室温度降到-40℃~-60℃温度,将培养皿移入干燥室;温度平衡后密闭干燥室,并开启抽气泵,维持干燥室气压小于5000帕斯卡24~72小时,然后升至常压后加热至40℃热烘1~3小时,再将得到的多孔材料置于40℃真空干燥箱内干燥72小时。4. Prefreeze the solution in a refrigerator at -10°C to -80°C for 8 to 24 hours; lower the temperature of the drying chamber of the freeze dryer to -40°C to -60°C, and move the petri dish into the drying chamber; temperature balance Finally, seal the drying room and turn on the air pump to keep the air pressure in the drying room less than 5000 Pascals for 24 to 72 hours, then raise it to normal pressure and heat to 40°C for 1 to 3 hours, then place the obtained porous material in a vacuum at 40°C Dry in a drying oven for 72 hours.
由模板法和冷冻干燥法相结合制备的PHB多孔支架材料,其支架的孔隙率由初始溶液的浓度决定,初始浓度越大,孔隙率越低(见图1);预冻温度影响平均孔径和孔径分布,预冻温度越低、孔径越小、预冻温度越高,孔径越大(如图2)。The porosity of the PHB porous scaffold material prepared by combining the template method and the freeze-drying method is determined by the concentration of the initial solution. The greater the initial concentration, the lower the porosity (see Figure 1); the pre-freezing temperature affects the average pore size and pore size Distribution, the lower the pre-freezing temperature, the smaller the pore size, and the higher the pre-freezing temperature, the larger the pore size (as shown in Figure 2).
本发明的聚羟基丁酸酯/聚乙二醇多孔支架材料价格低廉、生物相容性好、亲/疏水平衡性可调、孔径大小及分布可控、能适应不同类型细胞的需要,同时保证了多孔材料的力学强度和生物质,如细胞的亲和性。该支架材料非常适于软骨组织细胞附着生长。The polyhydroxybutyrate/polyethylene glycol porous scaffold material of the present invention has low price, good biocompatibility, adjustable hydrophilic/hydrophobic balance, controllable pore size and distribution, and can adapt to the needs of different types of cells, while ensuring The mechanical strength of porous materials and the affinity of biomass, such as cells. The scaffold material is very suitable for attachment and growth of cartilage tissue cells.
附图说明Description of drawings
图1、不同预冻温度下聚羟基丁酸酯/聚乙二醇多孔支架材料孔径的微观电镜图。Figure 1. Microscopic electron microscope images of the pore size of the polyhydroxybutyrate/polyethylene glycol porous scaffold material at different pre-freezing temperatures.
图2、不同初始浓度对聚羟基丁酸酯/聚乙二醇多孔支架材料孔隙率(%)的影响曲线图。Fig. 2 is a graph showing the influence of different initial concentrations on the porosity (%) of the polyhydroxybutyrate/polyethylene glycol porous scaffold material.
具体实施方式 Detailed ways
1.取分子量为4×105的聚羟基丁酸酯4g和分子量为6000的聚乙二醇0.4g,1. Get the polyhydroxybutyrate 4g that molecular weight is 4 * 105 and the polyethylene glycol 0.4g that molecular weight is 6000,
2.放入80ml氯仿中,40℃下搅拌2小时,达到完全溶解后将溶液转移至于100ml容量瓶,添加氯仿溶液,得到100ml聚羟基丁酸酯/聚乙二醇氯仿溶液(A);取SPAN60 0.12g溶于70℃60ml去离子水中,得到稳定的模板乳液(B);取溶液(A)20ml和(B)0.5ml混合在一起,在700转/分钟下搅拌3小时,待溶液混合均匀稳定后,转移至60mm玻璃培养皿中,置入-80℃低温冰箱中预冻24小时;控制冷冻干燥机干燥室温度至-50℃,将含预冻体的培养皿移入干燥室;温度平衡后密闭干燥室并开启抽气泵,维持干燥室气压小于50μatm,保持48小时;然后升至常压后加热至40℃热烘2小时,再将得到的多孔材料置于40℃真空干燥箱内干燥72小时。2. Put in 80ml of chloroform, stir at 40°C for 2 hours, transfer the solution to a 100ml volumetric flask after complete dissolution, and add chloroform solution to obtain 100ml polyhydroxybutyrate/polyethylene glycol chloroform solution (A); take Dissolve 0.12g of SPAN60 in 60ml of deionized water at 70°C to obtain a stable template emulsion (B); take 20ml of solution (A) and 0.5ml of (B) and mix together, stir at 700 rpm for 3 hours, and wait for the solution to mix After being uniform and stable, transfer to a 60mm glass petri dish, and place it in a -80°C low-temperature refrigerator for pre-freezing for 24 hours; control the temperature in the drying room of the freeze dryer to -50°C, and move the petri dish containing the pre-frozen body into the drying room; temperature After balancing, close the drying room and turn on the air pump, keep the air pressure in the drying room less than 50μatm, and keep it for 48 hours; then rise to normal pressure and heat to 40°C for 2 hours, then place the obtained porous material in a 40°C vacuum drying oven Dry for 72 hours.
3.取分子量为2×105的聚羟基丁酸酯11g和分子量为4000的聚乙二醇7.7g,放入80ml氯仿中,40℃下搅拌2小时,达到完全溶解后将溶液转移至于100ml容量瓶,添加氯仿溶液,得到100ml聚羟基丁酸酯/聚乙二醇氯仿溶液(A);取TWEEN60 0.12g溶于70℃60ml去离子水中,得到稳定的模板乳液(B);取溶液(A)20ml和(B)0.5ml混合在一起,在700转/分钟下搅拌3小时,待溶液混合均匀稳定后,转移至60mm玻璃培养皿中,置入-80℃低温冰箱中预冻24小时;控制冷冻干燥机干燥室温度至-50℃,将含预冻体的培养皿移入干燥室;温度平衡后密闭干燥室并开启抽气泵,维持干燥室气压小于50μatm,保持48小时;然后升至常压后加热至40℃热烘2小时,再将得到的多孔材料置于40℃真空干燥箱内干燥72小时。3. Take 11g of polyhydroxybutyrate with a molecular weight of 2× 105 and 7.7g of polyethylene glycol with a molecular weight of 4000, put them into 80ml of chloroform, stir at 40°C for 2 hours, and transfer the solution to 100ml after complete dissolution Volumetric flask, add chloroform solution, obtain 100ml polyhydroxybutyrate/polyethylene glycol chloroform solution (A); Get TWEEN60 0.12g and dissolve in 70 ℃ 60ml deionized water, obtain stable template emulsion (B); Take solution ( A) 20ml and (B) 0.5ml are mixed together and stirred at 700 rpm for 3 hours. After the solution is mixed evenly and stably, transfer it to a 60mm glass petri dish and place it in a -80°C low-temperature refrigerator for 24 hours. ;Control the temperature of the drying chamber of the freeze dryer to -50°C, move the petri dish containing the pre-frozen body into the drying chamber; after the temperature is balanced, close the drying chamber and turn on the air pump to keep the air pressure in the drying chamber less than 50μatm for 48 hours; then rise to After normal pressure, it was heated to 40° C. and baked for 2 hours, and then the obtained porous material was dried in a vacuum oven at 40° C. for 72 hours.
4.取分子量为6×105的聚羟基丁酸酯8g和分子量为20000的聚乙二醇2g,放入80ml氯仿中,40℃下搅拌2小时,达到完全溶解后将溶液转移至于100ml容量瓶,添加氯仿溶液,得到100ml聚羟基丁酸酯/聚乙二醇氯仿溶液(A);取AOT 0.12g溶于70℃60ml去离子水中,得到稳定的模板乳液(B);取溶液(A)20ml和(B)0.5ml混合在一起,在700转/分钟下搅拌3小时,待溶液混合均匀稳定后,转移至60mm玻璃培养皿中,置入-80℃低温冰箱中预冻24小时;控制冷冻干燥机干燥室温度至-50℃,将含预冻体的培养皿移入干燥室;温度平衡后密闭干燥室并开启抽气泵,维持干燥室气压小于50μatm,保持48小时;然后升至常压后加热至40℃热烘2小时,再将得到的多孔材料置于40℃真空干燥箱内干燥72小时。4. Take 8g of polyhydroxybutyrate with a molecular weight of 6× 105 and 2g of polyethylene glycol with a molecular weight of 20,000, put them into 80ml of chloroform, stir at 40°C for 2 hours, and transfer the solution to a capacity of 100ml after complete dissolution Bottle, add chloroform solution, obtain 100ml polyhydroxybutyrate/polyethylene glycol chloroform solution (A); Take AOT 0.12g and dissolve in 70 ℃ 60ml deionized water, obtain stable template emulsion (B); Take solution (A ) 20ml and (B) 0.5ml are mixed together, stirred at 700 rpm for 3 hours, after the solution is uniformly mixed and stable, transferred to a 60mm glass petri dish, and placed in a -80°C low-temperature refrigerator for 24 hours to pre-freeze; Control the temperature of the drying room of the freeze dryer to -50°C, move the petri dish containing the pre-frozen body into the drying room; after the temperature is balanced, close the drying room and turn on the air pump to keep the air pressure in the drying room less than 50μatm for 48 hours; then rise to normal temperature. After pressing, it was heated to 40° C. and baked for 2 hours, and then the obtained porous material was dried in a vacuum oven at 40° C. for 72 hours.
Claims (4)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021163499A CN1168506C (en) | 2002-03-28 | 2002-03-28 | Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB021163499A CN1168506C (en) | 2002-03-28 | 2002-03-28 | Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1380114A CN1380114A (en) | 2002-11-20 |
| CN1168506C true CN1168506C (en) | 2004-09-29 |
Family
ID=4744079
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB021163499A Expired - Fee Related CN1168506C (en) | 2002-03-28 | 2002-03-28 | Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1168506C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201119173D0 (en) | 2011-11-07 | 2011-12-21 | Fujifilm Mfg Europe Bv | Porous tissue scaffolds |
| CN103275328B (en) * | 2013-06-14 | 2015-06-17 | 西北师范大学 | Synthetic method of polyhydroxybutyrate-artemisia sphoerocephala polysaccharide copolymer |
| CN103751852B (en) * | 2014-01-24 | 2015-06-17 | 天津理工大学 | Preparation method of three-dimensional artificial random porous structure tissue engineering scaffold |
| CN105147423B (en) * | 2015-08-04 | 2017-03-22 | 天津理工大学 | Preparation method of tissue engineering scaffold with three-dimensional composite porous structure |
| CN107699982A (en) * | 2017-10-31 | 2018-02-16 | 无锡中科光远生物材料有限公司 | A kind of preparation method of modified polyhydroxyalkanoate composite fibrous scaffold |
| CN114425101B (en) * | 2022-01-21 | 2022-07-22 | 北京大学口腔医学院 | Micro-nano double-layer structure antibacterial bracket and preparation method and application thereof |
-
2002
- 2002-03-28 CN CNB021163499A patent/CN1168506C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1380114A (en) | 2002-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Savina et al. | Design and assessment of biodegradable macroporous cryogels as advanced tissue engineering and drug carrying materials | |
| Shachar et al. | Cardiac tissue engineering, ex-vivo: design principles in biomaterials and bioreactors | |
| Baldino et al. | Chitosan scaffolds formation by a supercritical freeze extraction process | |
| CN102319449B (en) | Poly(lactic-co-glycolic acid)-based growth factor gradient release microsphere stent as well as preparation method and application thereof | |
| CN112250892A (en) | Gelatin microsphere and preparation method and application thereof | |
| CN102836016A (en) | Implantable degradable device for promoting nerve regeneration after peripheral nerve transplantation | |
| US12403221B2 (en) | Preparation of composite gels, polymer scaffolds, aggregates and films comprising soluble cross-linked chitosan and uses thereof | |
| CN101264341A (en) | Three-dimensional porous tissue engineering scaffold material, its preparation and application | |
| CN105802916B (en) | A kind of preparation and use method of chitosan hydrogel three-dimensional cell culture medium | |
| CN1168506C (en) | Polyhydroxybutyrate/polyethylene glycol porous scaffold material and preparation method thereof | |
| CN107537063B (en) | A composite porous scaffold containing carbon nanotubes and its preparation method | |
| Hong et al. | Biomedical polymer scaffolds mimicking bone marrow niches to advance in vitro expansion of hematopoietic stem cells | |
| Zhao et al. | Understanding cell homing-based tissue regeneration from the perspective of materials | |
| KR20090075503A (en) | Preparation method of biodegradable porous hybrid carrier and artificial organ manufactured using the same | |
| CN109432494A (en) | A kind of surface has the PEEK microballoon and its preparation method and application of special topology | |
| Chhibber et al. | Hydrogels in tissue engineering | |
| CN104587525A (en) | Scaffold containing platelets and hyaluronic acid and preparation method of scaffold | |
| CN113368304B (en) | Method for preparing multifunctional sodium alginate scaffold embedded with drug-loaded microspheres by using in-situ emulsification-based 3D printing technology | |
| Saptaji et al. | Review of the Potential use of Poly (lactic-co-glycolic acid) as Scaffolds in Bone Tissue Recovery | |
| Cai et al. | Surface modification of three-dimensional poly (d, l-lactic acid) scaffolds with baicalin: a histological study | |
| CN112370571A (en) | Bone tissue engineering scaffold material for treating jaw and face bone defect and synthesis method thereof | |
| Hu et al. | Surface‐modified pliable PDLLA/PCL/β‐TCP scaffolds as a promising delivery system for bone regeneration | |
| CN117599243A (en) | Bone tissue engineering scaffold material and preparation method thereof | |
| RU2740380C1 (en) | Bioengineered structure based on bacterial alginate and probiotic bacteria and method for production thereof | |
| CN102475908A (en) | Porous scaffold material for biomedicine and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |